These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 27586372)
41. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition. Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636 [TBL] [Abstract][Full Text] [Related]
42. ID1 Mediates Escape from TGFβ Tumor Suppression in Pancreatic Cancer. Huang YH; Hu J; Chen F; Lecomte N; Basnet H; David CJ; Witkin MD; Allen PJ; Leach SD; Hollmann TJ; Iacobuzio-Donahue CA; Massagué J Cancer Discov; 2020 Jan; 10(1):142-157. PubMed ID: 31582374 [TBL] [Abstract][Full Text] [Related]
43. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells. Hiemer SE; Szymaniak AD; Varelas X J Biol Chem; 2014 May; 289(19):13461-74. PubMed ID: 24648515 [TBL] [Abstract][Full Text] [Related]
44. RNF11 is a multifunctional modulator of growth factor receptor signalling and transcriptional regulation. Azmi P; Seth A Eur J Cancer; 2005 Nov; 41(16):2549-60. PubMed ID: 16226459 [TBL] [Abstract][Full Text] [Related]
45. miR-203 inhibits ovarian tumor metastasis by targeting BIRC5 and attenuating the TGFβ pathway. Wang B; Li X; Zhao G; Yan H; Dong P; Watari H; Sims M; Li W; Pfeffer LM; Guo Y; Yue J J Exp Clin Cancer Res; 2018 Sep; 37(1):235. PubMed ID: 30241553 [TBL] [Abstract][Full Text] [Related]
46. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer. Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344 [TBL] [Abstract][Full Text] [Related]
47. Targeting TGFβ signal transduction for cancer therapy. Liu S; Ren J; Ten Dijke P Signal Transduct Target Ther; 2021 Jan; 6(1):8. PubMed ID: 33414388 [TBL] [Abstract][Full Text] [Related]
48. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression. Chen H; Lorton B; Gupta V; Shechter D Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440 [TBL] [Abstract][Full Text] [Related]
49. A step-by-step microRNA guide to cancer development and metastasis. Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501 [TBL] [Abstract][Full Text] [Related]
50. A Novel TGFβ Trap Blocks Chemotherapeutics-Induced TGFβ1 Signaling and Enhances Their Anticancer Activity in Gynecologic Cancers. Zhu H; Gu X; Xia L; Zhou Y; Bouamar H; Yang J; Ding X; Zwieb C; Zhang J; Hinck AP; Sun LZ; Zhu X Clin Cancer Res; 2018 Jun; 24(12):2780-2793. PubMed ID: 29549162 [No Abstract] [Full Text] [Related]
51. Transforming growth factor-β suppresses metastasis in a subset of human colon carcinoma cells. Simms NA; Rajput A; Sharratt EA; Ongchin M; Teggart CA; Wang J; Brattain MG BMC Cancer; 2012 Jun; 12():221. PubMed ID: 22672900 [TBL] [Abstract][Full Text] [Related]
52. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Schliekelman MJ; Gibbons DL; Faca VM; Creighton CJ; Rizvi ZH; Zhang Q; Wong CH; Wang H; Ungewiss C; Ahn YH; Shin DH; Kurie JM; Hanash SM Cancer Res; 2011 Dec; 71(24):7670-82. PubMed ID: 21987723 [TBL] [Abstract][Full Text] [Related]
53. USP11 Enhances TGFβ-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis. Garcia DA; Baek C; Estrada MV; Tysl T; Bennett EJ; Yang J; Chang JT Mol Cancer Res; 2018 Jul; 16(7):1172-1184. PubMed ID: 29724812 [TBL] [Abstract][Full Text] [Related]
54. ZNF224 is a mediator of TGF-β pro-oncogenic function in melanoma. Cesaro E; Pastore A; Polverino A; Manna L; Divisato G; Quintavalle C; Sanzo MD; Faniello MC; Grosso M; Costanzo P Hum Mol Genet; 2021 Nov; 30(22):2100-2109. PubMed ID: 34181020 [TBL] [Abstract][Full Text] [Related]
55. Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells. Allen CE; Du J; Jiang B; Huang Q; Yakovich AJ; Barnard JA Neoplasia; 2008 Oct; 10(10):1073-82. PubMed ID: 18813357 [TBL] [Abstract][Full Text] [Related]
56. Intravital imaging illuminates transforming growth factor beta signaling switches during metastasis. Giampieri S; Pinner S; Sahai E Cancer Res; 2010 May; 70(9):3435-9. PubMed ID: 20424121 [TBL] [Abstract][Full Text] [Related]
58. TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy. Cozzolino AM; Alonzi T; Santangelo L; Mancone C; Conti B; Steindler C; Musone M; Cicchini C; Tripodi M; Marchetti A J Hepatol; 2013 Jan; 58(1):65-72. PubMed ID: 22960426 [TBL] [Abstract][Full Text] [Related]
59. Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis. Bjerke GA; Yang CS; Frierson HF; Paschal BM; Wotton D Oncogene; 2014 Jul; 33(28):3660-7. PubMed ID: 23995785 [TBL] [Abstract][Full Text] [Related]
60. Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast cancer cell migration and tumor local invasion. Dai M; Al-Odaini AA; Fils-Aimé N; Villatoro MA; Guo J; Arakelian A; Rabbani SA; Ali S; Lebrun JJ Breast Cancer Res; 2013 Jun; 15(3):R49. PubMed ID: 23786849 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]